In the largest deal in country’s history, Israel’s Teva has acquired Dublin-based Allergan for $40.5 billion. Teva stated “This strategic acquisition brings together two leading generics businesses with complementary strengths, brands and cultures, providing patients with more affordable access to quality medicines, and creating significant financial benefits for Teva stockholders.”
http://www.globes.co.il/en/article-teva-buying-allergan-generics-for-405b-1001055906